Tag: development stage

GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it entered into a securities purchase agreement with an accredited investor for aggregate gross proceeds of $4.25 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for potential acquisitions, marketing and other general corporate purposes.

EfTEN United Property Fund earned a net profit of 170 thousand euros in May and 1,32 million euros in the first five months of 2025 (compared to 357 thousand euros in the same time last year). In May, the fund made a cash distribution to investors in the amount of 1.47 million euros, or 57-euro cents per unit. As a result, the fund's net asset value (NAV) decreased by 4,4% and was 11,02 euros per unit at the end of May. Without the distribution the NAV of EfTEN United Property Fund would have increased by 0,6% in May.